Breast implant maker Allergan issued a worldwide recall Wednesday for textured models because of a link to a rare form of cancer.
The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan’s Biocell breast implants with a textured surface account for a disproportionate share of rare lymphoma cases. The move follows similar action in France, Australia and Canada.is not recommending women with the implants have them removed if they are not experiencing problems.
As recently as May, the FDA said that the danger did not warrant a national ban on the devices. But the FDA said Wednesday that new data show a direct link to cancer with Allergan’s implants not seen with other textured implants. The FDA said the latest figures show more than 80 percent of the 570 confirmed cases of the lymphoma worldwide have been linked to Allergan implants. The updated figures reflect 116 new cases of the cancer since the FDA last released figures earlier this year.The new numbers still reflect a rare disease considering an estimated 10 million women globally have breast implants.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA asks Allergan to recall textured breast implants worldwideAllergan Plc said on Wednesday it was recalling its Biocell textured breast impl...
Leer más »
FDA requests recall of Allergan textured breast implants linked to cancerJUST IN: In a major reversal, FDA now says they are asking breast implant maker Allergan to recall its textured implants after the agency found a higher risk of cancer linked to those devices.
Leer más »
FDA Now Wants Textured Breast Implants to Be RecalledAlmost three months after the Food and Drug Administration chose not to enact a wholesale ban of textured breast implants—a type of implant linked to a rare cancer—the agency has asked the breast implant maker Allergan to recall its textured implants currently available in the United States. According to the FDA, Allergan is “moving forward with a worldwide recall.”
Leer más »
Blackstone President Jonathan Gray Donates $25 Million To Tackle Deadly Breast Cancer GeneWith his latest donation, the billionaire private equity mogul has given more than $100 million to BRCA research in hopes of preventing related cancers through early detection and treatment.
Leer más »
Blackstone President Jonathan Gray Donates $25 Million To Tackle Deadly Breast Cancer GeneWith his latest donation, the billionaire private equity mogul has given more than $100 million to BRCA research in hopes of preventing related cancers through early detection and treatment.
Leer más »